ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Gsk3beta Regulates the Resolution of Liver Ischemia Reperfusion Injury via MerTK

H. Zhang1, M. Ni2, J. Zhang1, R. Busuttil1, J. Kupiec-Weglinski1, W. Li3, X. Wang2, Y. E. Zhai1

1Dumont-UCLA Transplant Center, Los Angeles, CA, 2The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 3China-Japan Union Hospital of Jilin University, JiLing, China

Meeting: 2022 American Transplant Congress

Abstract number: 651

Keywords: Inflammation, Kinases, Liver, Warm ischemia

Topic: Basic Science » Basic Science » 14 - Ischemia Reperfusion

Session Information

Session Name: Ischemia Reperfusion

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: We have shown previously that glycogen synthase kinase β (Gsk3β) regulates liver inflammatory activation against ischemia/reperfusion injury (IRI). The question of whether it also plays a role in the inflammation resolution and the restoration of tissue homeostasis post IR has not been properly addressed. As the dominant innate immune cells in livers, macrophages are heterogenous. Whether Gsk3β differentially regulates resident vs. infiltrating types of tissue macrophages at different stages of the inflammatory response remains to be determined.

*Methods: In a murine liver partial warm ischemia (90m) reperfusion injury (IRI) model, we compared myeloid-specific Gsk3b KO mice and their controls in the pathogenesis of liver IRI at both the activation and resolution stage (6h and day 3-7 post reperfusion). Kupffer cells were selectively depleted by low dose of clodronate liposomes. Bone marrow-derived macrophages were used to reconstitute diphtheria toxin-treated CD11b-DTR mice.

*Results: Gsk3β inhibitory phosphorylation at serine 9 was increased in IR livers at both the activation and resolution stages of the disease process. Myeloid Gsk3β deficiency not only reduced hepatocellular damages at 6h, but also facilitated the resolution of liver IRI (at day 3 vs. day 7 in WT mice post reperfusion). This was demonstrated at the recovery of tissue injury (histology) /inflammatory gene expression (qRT-PCR), as well as the clearance/reprogramming of infiltrating neutrophils/macrophages (FACS). Treatments of mice with anti-IL-10 Ab- or clodronate liposomes prior to the onset of liver ischemia diminished the differences in the severities of liver injuries at 6h post reperfusion between WT and the KO mice. However, the resolution of liver IRI remained accelerated in these treated KO mice. The reconstitution of CD11b-DTR mice with Gsk3β deficient bone marrow-derived macrophages (BMMs) facilitated the resolution of liver IRI, as compared with those with WT cells. At the cellular level, Gsk3β deficiency promoted MerTK induction in liver infiltrating macrophages in vivo and in LXR-stimulated BMMs in vitro. Gsk3 pharmacological inhibition facilitated the resolution of liver IRI in WT, but not myeloid MerTK KO, mice.

*Conclusions: Gsk3β regulates the resolution of liver IRI independent of its roles in the activation stage of the disease. Gsk3 inactivation promotes the pro-resolution function in liver infiltrating macrophages by facilitating MerTK induction.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Zhang H, Ni M, Zhang J, Busuttil R, Kupiec-Weglinski J, Li W, Wang X, Zhai YE. Gsk3beta Regulates the Resolution of Liver Ischemia Reperfusion Injury via MerTK [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/gsk3beta-regulates-the-resolution-of-liver-ischemia-reperfusion-injury-via-mertk/. Accessed May 18, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences